Breaking News

Covance Launches Immunology & Immunotoxicology Unit

The new team will be dedicated to the specific needs of biologic drug development

LabCorp‘s Covance business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the specific needs of biologic drug development.    The company says that this new team brings together Covance’s operational expertise in flow cytometry, immunoassays and cell-based assays with its scientific expertise in immunotoxicology study design, direction and operation to provide a more comprehensive offering for large-molecule drugs.   “With the formation of t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters